Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

(2012) G García-Santos et al.   BRITISH JOURNAL OF CANCER

Melatonin, A Natural Programmed Cell Death Inducer in Cancer

(2012) M. Sánchez-Hidalgo et al.   CURRENT MEDICINAL CHEMISTRY

Gene regulation by melatonin linked to epigenetic phenomena

(2012) Ahmet Korkmaz et al.   GENE

The ABCG2 resistance network of glioblastoma

(2011) Anne-Marie Bleau et al.   CELL CYCLE

Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells

(2011) Ana M. Sánchez-Sánchez et al.   FREE RADICAL RESEARCH

Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas

(2011) Marta M. Alonso et al.   PLoS One

Melatonin: Action as antioxidant and potential applications in human disease and aging

(2010) Dominique Bonnefont-Rousselot et al.   TOXICOLOGY

Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

(2009) Vanesa Martín et al.   CANCER LETTERS

The Side Story of Stem-like Glioma Cells

(2009) Anders I. Persson et al.   Cell Stem Cell

Brain tumor treatment increases the number of cancer stem-like cells

(2009) Nikki Charles et al.   Expert Review of Neurotherapeutics

Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance–associated protein genes

(2008) F. Jin et al.   NEUROSCIENCE